Repligen corporation

Overcome common challenges.

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in and is headquartered in Waltham, Massachusetts. Yahoo Finance.

Repligen corporation

Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs. Before , Repligen maintained dual capabilities in developing pharmaceutical therapeutics drug discovery and development and the development of materials supporting biological drug manufacture bioprocessing business. Repligen employs a direct sales model to users of its products in the United States, with some sales through intermediaries in "certain foreign markets". As a consequence of current operations, about one-third each of revenue and cost and expenses are denominated in Swedish krona currency, the remaining two-thirds denominated in United States dollars ; this presents a risk to the business based on unpredictable fluctuations in currency exchange rates. The company's Protein A-related offerings are supported by proprietary technology, trade secrets and patent filings. Repligen's company headquarters are housed together with its manufacturing facility in Waltham, Massachusetts. Repligen maintains manufacturing facilities in Waltham, Massachusetts and Lund, Sweden. The lease on the main Waltham facility extends through Alexander Rich was a co-founder of Repligen and served as Chairman Emeritus [14] of Repligen's board of directors. Rich had been a member of the Board since He used to be the John D. In early , Repligen licensed technology from BioFlash which it subsequently incorporated into the OPUS line of pre-packed chromatography columns. In September , Repligen acquired a fluid management company, Metenova. In , an agreement was struck to divest certain intellectual property rights to Bristol-Myers Squibb around the drug Orencia in exchange for ongoing royalty payments through the end of At the end of , Repligen out-licensed its spinal muscular atrophy program, in particular the small molecule candidate drug RG , to Pfizer.

Sign in to view your mail. Key Financial Charts.

Powered by. Repligen Corp Repligen is a life science company that develops and commercializes bioprocessing technologies for the manufacturing of biological drugs. Its products include upstream and downstream filtration, chromatography products, fluid management, cell culture supplements, ligands, and operating room disposables. The company also provides solutions to overcome the development and production of modalities into a new class of drugs. Its services comprise hands-on-process and implementation consultation services. Repligen is headquartered in Waltham, Massachusetts, the US. History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

We saw strong ratings and rankings as a result and are pleased to share this next progress report, while continuing to work toward positively impacting some of our more challenging initiatives and collaboration-based goals. Below are just a few of the Sustainability Report highlights. Report data is through year end unless otherwise noted. About Repligen Corporation Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.

Repligen corporation

Tony J. Strategically, our three acquisitions of Polymem, Avitide and BioFlex position us well to continue to drive above market growth in Our financial guidance for the fiscal year is based on expectations for our existing business and includes the financial impact of our acquisitions of BioFlex Solutions which closed on December 16, , Avitide Inc. The guidance below excludes the impact of potential additional acquisitions and future fluctuations in foreign currency exchange rates. Conference Call Repligen will host a conference call and webcast today, February 17, , at a. EST, to discuss fourth quarter and full year financial results and corporate developments. The conference call will be accessible by dialing toll-free for domestic callers or for international callers.

Olympic nip slips

About Our Ads Sitemap. Tools Tools. Key Financial Charts. Simplify and intensify. Authority control databases ISNI. Telephone 1 Director; Chief Executive Officer. Be the leader. Our mission is to inspire advances in bioprocessing as a trusted partner in the production of biologic drugs that improve human health worldwide. August

The Company will issue a press release before the market opens and will host a conference call at a. ET to discuss business updates and financial results for the three- and nine-month reporting periods ended September 30,

Repligen completes the acquisition of Metenova. Article Talk. Click on the image highlights to see key elements of chromatography redesigned. Book a demo. Headquarters United States of America. The addition of FlexBiosys complements and vertically integrates our systems offering, providing a more complete single-use fluid management portfolio of products for our biopharmaceutical manufacturing customers. The company was incorporated in and is headquartered in Waltham, Massachusetts. Currency in USD. Powered by. Visit Corporate Site.